Pressreleases

Analysis of mAb’s and ADC’s

The team of Szabolcs Fekete and Davy Guillarme (Univ. Geneva, CH) contributed two new papers about the analysis of monoclonal antibodies (mAb’s) and conjugated molecules in Journal of Pharmaceutical and Biomedical Analysis.

EAS-Lecture: Modeling HPLC Method Robustness

Imre Molnár will lecture at Eastern Analytical Symposium in Somerset, New Jersey, on the modeling of HPLC method robustness. Tolerance limits are crucial parameters in U(H)PLC method modeling if a method should yield decent separations, even if many influential factors change ALL at the same time.

Woodley Equipment Company Inc. Exhibiting at Outsourcing in Clinical Trials West Coast

Woodley Equipment Company is exhibiting at Outsourcing in Clinical Trials West Coast taking place at the San Mateo Event Center, California, on Wednesday 10th – Thursday 11th March 2016.

Through the Skin

Transdermal systems are pharmaceutical patches that transport the active substances directly into the bloodstream through the skin – often with fewer side effects than tablets.

Axol Bioscience Announces Chas Bountra as Scientific Advisory Board Member

World leading pioneer on drug discovery through open innovation, joins the stem cell disease model specialists.

Axol Bioscience Introduces Steve Rees as Scientific Advisory Board Member at SLAS 2016

The stem cell disease model specialists also showcase expanded range of primary and iPSC-derived cells for drug discovery.

Blending Solutions for Food and Pharma

Scott Heffern: Our wheelhouse and blending is IBC blending, containment blending, many different words for it. We make many different types of blenders. We make V-blenders, double cone blenders, kind of the old standards, check blenders.

Sir Ranulph Fiennes Visits Source BioScience to Celebrate the Launch of the World’s First -70°C Walk-in Chamber

With temperatures regularly reaching -70°C, the coldest place on earth is unsurprisingly the Antarctic. Source BioScience is now able to replicate these bone-chilling temperatures in an innovative, efficient storage solution.

The Stem Cell Disease Model Specialists Recruit Leading Biologist, Prof Xianmin Zeng, as Chief Scientific Officer

Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced Prof Xianmin Zeng, PhD as Chief Scientific Officer (CSO). Prof Zeng is an accomplished biologist with over 15 years of academic expertise in the development of stem cell technologies and its applications. A biotech entrepreneur with an extensive list of peer-reviewed publications, she is a well-established and internationally-recognised leader in the creation of disease models for drug discovery.